Latest News about psychedelics
Recent news which mentions psychedelics
Ultra-Low-Dose Ketamine May Offer Relief For Opioid Withdrawal, Study Finds
September 18, 2024
From Benzinga
Investors Back Awakn's Psychedelic Therapies, As Company Doubles Private Placement To $2M
September 18, 2024
From Benzinga
DEA Endorses New, Simplified Test To Determine Marijuana's Medical Uses Amid Rescheduling Debate: Could It Also Apply To Psychedelics?
September 17, 2024
Tickers
NEWS
From Benzinga
From Benzinga
86% Of Drug Researchers Admit To Drug Use: NYU Study
September 16, 2024
From Benzinga
Norwalk, CT's First Cannabis Dispensary Faces Solar Panel Dilemma: Tree Shade And Low ROI Hinder Compliance
September 16, 2024
Tickers
NEWS
From Benzinga
Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition
September 16, 2024
From Benzinga
Nebraska Medical Cannabis Legalization Heads Into November Election Amid Signature Controversy
September 16, 2024
Tickers
NEWS
From Benzinga
Marijuana Sales Hit Record Highs In These 6 US States: Is Marijuana Outpacing Alcohol?
September 13, 2024
Tickers
NEWS
From Benzinga
Magic Mushrooms Boosted Humanity's Evolutionary Success, New Study Says: Did Psilocybin Make Early Humans Better Hunters?
September 13, 2024
From Benzinga
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
September 12, 2024
From Benzinga
LSD, MDMA And d-Amphetamine: Study Provides New Insights Into Neurobiological Effects
September 12, 2024
From Benzinga
Multidisciplinary Association For Psychedelic Studies Eyes State-Level Legalization After FDA Denial Of MDMA Therapy
September 11, 2024
From Benzinga